Dmitry Tchapyjnikov

Dmitry Tchapyjnikov

Auto-generated profile, based on publicly available information

Dmitry Tchapyjnikov

Division of Pediatric Neurology, Duke University Medical Center, Duke University, Durham, NC, United States

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2009 in Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
PDF file
PGPatricia A. Gonzales
Patricia A. Gonzales
TPTrairak Pisitkun
Trairak Pisitkun
JHJason D. Hoffert
Jason D. Hoffert
DTDmitry Tchapyjnikov
Dmitry Tchapyjnikov
RSRobert A. Star
Robert A. Star
MKMark A. Knepper
Mark A. Knepper
Normal human urine contains large numbers of exosomes, which are 40- to 100-nm vesicles that originate as the internal vesicles in multivesicular bodies from every renal epithelial cell type facing the urinary space. Here, we used LC-MS/MS to profile the proteome of human urinary exosomes. Overall, the analysis identified 1132 proteins unambiguously, including 177 that are represented on the Online Mendelian Inheritance in Man database of disease-related genes, suggesting that exosome analysis is a potential approach to discover urinary biomarkers. We extended the proteomic analysis to phosphoproteomic profiling using neutral loss scanning, and this yielded multiple novel phosphorylation sites, including serine-811 in the thiazide-sensitive Na-Cl co-transporter, NCC. To demonstrate the potential use of exosome analysis to identify a genetic renal disease, we carried out immunoblotting of exosomes from urine samples of patients with a clinical diagnosis of Bartter syndrome type I, showing an absence of the sodium-potassium-chloride co-transporter 2, NKCC2. The proteomic data are publicly accessible at http://dir.nhlbi.nih.gov/papers/lkem/exosome/.

1 September 2008 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
JHJason D. Hoffert
Jason D. Hoffert
RFRobert Fenton Fenton
Robert Fenton Fenton
HMHanne B. Moeller
Hanne B. Moeller
BSBrigitte Simons
Brigitte Simons
DTDmitry Tchapyjnikov
Dmitry Tchapyjnikov
MKMark A. Knepper
Mark A. Knepper
Vasopressin controls water excretion through regulation of aquaporin-2 (AQP2) trafficking in renal collecting duct cells. Using mass spectrometry, we previously demonstrated four phosphorylated serines (Ser256, Ser261, Ser264, and Ser269) in the carboxyl-terminal tail of rat AQP2. Here, we used phospho-specific antibodies and protein mass spectrometry to investigate the roles of vasopressin and cyclic AMP in the regulation of phosphorylation at Ser269 and addressed the role of this site in AQP2 trafficking. The V2 receptor-specific vasopressin analog dDAVP increased Ser(P)269-AQP2 abundance more than 10-fold, but at a rate much slower than the corresponding increase in Ser256 phosphorylation. Vasopressin-mediated changes in phosphorylation at both sites were mimicked by cAMP addition and inhibited by protein kinase A (PKA) antagonists. In vitro kinase assays, however, demonstrated that PKA phosphorylates Ser256, but not Ser269. Phosphorylation of AQP2 at Ser269 did not occur when Ser256 was replaced by an unphosphorylatable amino acid, as seen in both S256L-AQP2 mutant mice and in Madin-Darby canine kidney cells expressing an S256A mutant, suggesting that Ser269 phosphorylation depends upon prior phosphorylation at Ser256. Immunogold electron microscopy localized Ser(P)269-AQP2 solely in the apical plasma membrane of rat collecting duct cells, in contrast to the other three phospho-forms (found in both apical plasma membrane and intracellular vesicles). Madin-Darby canine kidney cells expressing an S269D “phosphomimic” AQP2 mutant showed constitutive localization at the plasma membrane. The data support a model in which vasopressin-mediated phosphorylation of AQP2 at Ser269:(a) depends on prior PKA-mediated phosphorylation of Ser256 and (b) enhances apical plasma membrane retention of AQP2.

1 April 2018 in JAMA Neurology
Verified
Journal Article
Open access
PDF file
MGMarina Gaínza-Lein
Marina Gaínza-Lein
IFIván Sánchez Fernández
Iván Sánchez Fernández
MJMichele Jackson
Michele Jackson
NANicholas S. Abend
Nicholas S. Abend
RARavindra Arya
Ravindra Arya
FGfor the Pediatric Status Epilepticus Research Group
for the Pediatric Status Epilepticus Research Group
Status epilepticus (SE) consists of a prolonged, self-sustaining seizure or repeated seizures without return to baseline neurological function.1 It is one of the most frequent life-threatening emergencies affecting approximately 17 to 23 per 100 000 children in the United States and Europe.2-4 The short-term mortality ranges from 3% to 9%,2,5 and the long-term mortality rate is 7%.5 Survivors of SE often have long-term sequelae, including cognitive and neurodevelopmental impairment, epilepsy, and recurrent SE.6-8

1 October 2007 in American Journal of Physiology-Renal Physiology
Verified
Journal Article
Closed access
PDF file
MBMitsi A. Blount
Mitsi A. Blount
JKJanet D. Klein
Janet D. Klein
CMChristopher F. Martin
Christopher F. Martin
DTDmitry Tchapyjnikov
Dmitry Tchapyjnikov
JSJeff M. Sands
Jeff M. Sands
UT-A1 is regulated by vasopressin and is localized to the apical membrane and intracellular compartment of inner medullary collecting duct (IMCD) cells. UT-A3 is also expressed in the IMCD and is regulated by forskolin in heterologous systems. The goal of the present study is to investigate mechanisms by which vasopressin regulates UT-A3 in rat IMCD. In fresh suspensions of rat IMCD, forskolin increases the phosphorylation of UT-A3, similar to UT-A1. Biotinylation studies indicate that UT-A3 is located in the plasma membrane. Forskolin treatment increases the abundance of UT-A3 in the plasma membrane similar to UT-A1. However, these two transporters do not form a complex through a protein-protein interaction, suggesting that transporter function is unique to each protein. While immunohistochemistry localized UT-A3 to the basal and lateral membranes, a majority of the staining was cytosolic. Immunohistochemistry of vasopressin-treated rat kidney sections also localized UT-A3 primarily to the cytosol with basal and lateral membrane staining but also showed some apical membrane staining in some IMCD cells. This suggests that under normal conditions, UT-A3 functions as the basolateral transporter but in a high cAMP environment, the transporter may move from the cytosol to all plasma membranes to increase urea flux in the IMCD. In summary, this study confirms that UT-A3 is located in the inner medullary tip where it is expressed in the basolateral membrane, shows that UT-A3 is a phosphoprotein in rat IMCD that can be trafficked to the plasma membrane independent of UT-A1, and suggests that vasopressin may induce UT-A3 expression in the apical plasma membrane of IMCD.

13 April 2006 in Physiological Genomics
Verified
Journal Article
Closed access
PDF file
TPTrairak Pisitkun
Trairak Pisitkun
JBJared Bieniek
Jared Bieniek
DTDmitry Tchapyjnikov
Dmitry Tchapyjnikov
GWGuanghui Wang
Guanghui Wang
WWWells W. Wu
Wells W. Wu
MKMark A. Knepper
Mark A. Knepper
The inner medullary collecting duct (IMCD) is an important site of vasopressin-regulated water and urea transport. Here we have used protein mass spectrometry to investigate the proteome of the IMCD cell and how it is altered in response to long-term vasopressin administration in rats. IMCDs were isolated from inner medullas of rats, and IMCD proteins were identified by liquid chromatography/tandem mass spectrometry (LC-MS/MS). We present a WWW-based “IMCD Proteome Database” containing all IMCD proteins identified in this study (n = 704) and prior MS-based identification studies (n = 301). We used the isotope-coded affinity tag (ICAT) technique to identify IMCD proteins that change in abundance in response to vasopressin. Vasopressin analog (dDAVP) or vehicle was infused subcutaneously in Brattleboro rats for 3 days, and IMCDs were isolated for proteomic analysis. dDAVP and control samples were labeled with different cleavable ICAT reagents (mass difference 9 amu) and mixed. This was followed by one-dimensional SDS-PAGE separation, in-gel trypsin digestion, biotin-avidin affinity purification, and LC-MS/MS identification and quantification. Responses to vasopressin for a total of 165 proteins were quantified. Quantification, based on semiquantitative immunoblotting of 16 proteins for which antibodies were available, showed a high degree of correlation with ICAT results. In addition to aquaporin-2 and γ-epithelial Na channel (γ-ENaC), five of the immunoblotted proteins were substantially altered in abundance in response to dDAVP, viz., syntaxin-7, Rap1, GAPDH, heat shock protein (HSP)70, and cathepsin D. A 28-protein vasopressin signaling network was constructed using literature-based network analysis software focusing on the newly identified proteins, providing several new hypotheses for future studies.

1 August 2018 in Epilepsy Research
Verified
Journal Article
Closed access
RARavindra Arya
Ravindra Arya
KPKatrina Peariso
Katrina Peariso
MGMarina Gaínza-Lein
Marina Gaínza-Lein
JHJessica Harvey
Jessica Harvey
ABAnn Bergin
Ann Bergin
TLTobias Loddenkemper
Tobias Loddenkemper